The XIENCE™ DES is proven to offer unparalleled patient outcomes during and long after percutaneous coronary interventions (PCI).1 With over 20 million implants and studied in 120+ clinical trials,* XIENCE™ Stent provides consistent long-term safety data out to 10 years.2 XIENCE™ Stent allows interventional cardiologists (ICs) to achieve the positive outcomes they want for their patients.
The newest DES in the XIENCE™ Family, XIENCE Skypoint™ Stent has an enhanced design that offers better expansion, excellent deliverability, a new 48 mm design, and trusted patient outcomes.1,4
XIENCE Sierra™ Stent has an enhanced design that offers deliverability, pushability, post dilatation expansion as well as an ultra-low profile and smoother crossing.†
* Data on file at Abbott. The 15 million implants is based on DES data through Q1 2020.
† Tests performed by and data on file at Abbott.
You are about to enter an Abbott country- or region-specific website.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions
Do you wish to continue and enter this website?